Inventiva Pharma
Entity

  • Inventiva Pharma

    Created in 2012
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    5,050

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    50 Rue de Dijon, 21121 Daix, France

    Daix

    France

  • Employees

    Scale: 51-200

    Estimated: 117

  • SIREN

    537530255

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    3 years, 6 months ago
Description
  • Value proposition

    A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.

    Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.

    Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc

  • Original language

    A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.

    Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.

Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services 		Other

26 May 2023


Similar entities
Last news
Show all articles
Social network dynamics